About 7 results found for searched term "89-00-9" (0.138 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M7178 | Quinolinic acid | NMDA |
| 2,3-Pyridinedicarboxylic acid | ||
| Quinolinic acid is a endogenous NMDA agonist and transmitter candidate. | ||
| M24742 | Selicrelumab | Others |
| CP-870,893; RO7009789 | ||
| Selicrelumab is an agonist CD40 antibody, induces changes in the tumor microenvironment. Selicrelumab can be used for the research of pancreatic cance and neoadjuvant study. | ||
| M57900 | Trelanserin | Others |
| Trelanserin | ||
| M11435 | ABR-238901 | Others |
| Abr-238901 is an orally effective S100A8/A9 blocker that inhibits the interaction of S100A8/A9 with its receptors RAGE (receptor for advanced glycation end products) and TLR4(Toll-like receptor 4). Abr-238901 has the potential to be used in myocardial infarction (MI) research. | ||
| M20751 | BRD6989 | CDK |
| BRD6989 is a selective inhibitor of CDK8 and CDK19. BRD6989 selectively binds a complex of CDK8 with an IC50 of ~200 nM. BRD6989 inhibits the kinase activity of recombinant CDK8 or CDK19 complexes. BRD6989 upregulates IL-10. BRD6989 is an analog of the natural product cortistatin A (dCA). | ||
| M22521 | ZINC00640089 | Akt |
| ZINC00640089 is a specific Lipocalin-2 (LCN2) inhibitor. ZINC00640089 inhibits cell proliferation, cell viability and reduces AKT phosphorylation levels in SUM149 cells. | ||
| M27954 | CBK289001 | PAR |
| CBK289001 is a tartrate-resistant acid phosphatase (TRAP/ACP5) inhibitor. CBK289001 inhibits TRAP 5bMV, TRAP 5bOX and TRAP 5aOX with IC50s of 125 µM, 4.21 µM and 14.2 µM, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
